Sean Snyder
About Sean Snyder
Sean Snyder serves as the Director of QA/RA at Pillar Biosciences Incorporated, where he has worked since 2022. He has extensive experience in quality assurance and regulatory affairs, having held various positions within the company and previously at Micron Products, Inc. and Syneron Candela.
Current Role at Pillar Biosciences
Sean Snyder serves as the Director of QA/RA at Pillar Biosciences Incorporated, a position he has held since 2022. In this role, he oversees quality assurance and regulatory affairs, ensuring compliance with industry standards. His leadership contributes to the company's commitment to quality in the medical device and in vitro diagnostics sectors. Snyder's extensive experience in these areas supports the development and implementation of effective quality management strategies.
Previous Experience at Pillar Biosciences
Prior to his current role, Sean Snyder held several positions at Pillar Biosciences Incorporated. He worked as a Quality Assurance Specialist from 2019 to 2020, then advanced to Quality Systems Manager from 2020 to 2021. He later served as Senior Manager of QA/RA from 2021 to 2022. Throughout his tenure, he gained comprehensive knowledge of quality management systems and regulatory compliance, enhancing the company's operational effectiveness.
Experience at Micron Products, Inc.
Sean Snyder's career includes significant experience at Micron Products, Inc., where he worked from 2012 to 2016. He began as a Quality Assurance Inspector and progressed to Quality Engineer, and Quality Assurance Technician/CMM Programmer. His roles involved ensuring product quality and compliance with industry standards, contributing to his strong foundation in quality assurance practices.
Education and Expertise
Sean Snyder studied at the State University of New York College at Potsdam, where he focused on Music Performance and Music Business from 2007 to 2013. His educational background, combined with his extensive experience in quality assurance and regulatory affairs, equips him with a unique perspective on compliance in the medical device and IVD sectors. He possesses a comprehensive understanding of the regulatory landscape, which informs his contributions to quality assurance strategies.